			Home About us Contact

Better Diagnostic (good + diagnostic)

Distribution by Scientific Domains

Medical Sciences	50%

Selected Abstracts

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C,

HEPATOLOGY, Issue 1 2008
Rachel Morra
No abstract is available for this article. [source]

Systematic epitope analysis of the p26 EIAV core protein

JOURNAL OF MOLECULAR RECOGNITION, Issue 4 2007
Adriana Soutullo
Abstract The major core protein of equine infectious anemia virus (EIAV), p26, is one of the primary immunogenic structural proteins during a persistent infection of horses and is highly conserved among antigenically variants of viral isolates. In order to investigate its immune profile in more detail for a better diagnostic, an epitope mapping was carried out by means of two libraries of overlapping peptide fragments prepared by simultaneous and parallel SPPS on derivatized cellulose membranes (SPOT synthesis). Polyclonal equine sera from infected horses were used for the biological assay. Particularly two promising continuous epitopes (NAMRHL and MYACRD) were localized on the C-terminal extreme of p26, region 194,222. A cyclic synthetic fragment of 29 amino acid residues containing the identified epitopes was designed and studied. A significant conformational change towards a helical structure was observed when the peptide was cyclized by a bridge between Cys198 and Cys218. This observation correlated with an improvement of its ability to be recognized by specific antibodies in an EIA (Enzyme-linked Immunosorbent assay). These results suggest that the conformationally restricted synthetic antigen adequately mimics the native structure of this region of p26 core protein. Copyright © 2007 John Wiley & Sons, Ltd. [source]

Oncogenes in thyroid cancer

CLINICAL OTOLARYNGOLOGY, Issue 5 2003
D.S. Kim
There have been significant advances in our understanding of carcinogenesis at the molecular level over the last 25 years. Oncogenes are of major interest as part of our search for knowledge surrounding the aetiology of cancer. There are several oncogenes associated with thyroid cancer. Detailed investigation of the nature and function of these tumour genes has provided important insights into both the tumour biology and the complex biochemical pathways of normal cellular functioning. Our knowledge of oncogene biology offers the hope of better diagnostic, therapeutic and prognostic modalities in our fight against this and other common cancers. Development of specific thyroid tumour markers and gene therapy is now a realistic prospect to supplement our present armamentarium of surgery and radiotherapy. This review aims to outline the pertinent information gained so far from studies of these oncogenes and provides both clinical relevance and fuel for further interest amongst the ENT thyroid community in this exciting area of research. [source]

A peptide-based immunoassay for antibodies against botulinum neurotoxin A

JOURNAL OF MOLECULAR RECOGNITION, Issue 1 2007
M. Zouhair Atassi
Abstract Cervical dystonia (CD) is due to neck-muscle spasms that cause pain and involuntary contractions resulting in abnormal neck movements and posture. Symptoms can be relieved by injecting the affected muscle with a botulinum neurotoxin (BoNT, usually type A or type B). The therapeutic benefits are impermanent and toxin injections need to be repeated every 3,6 months. In a very small percentage of patients (less with BoNT/A than with BoNT/B) the treatment elicits blocking anti-toxin antibodies (Abs), which reduce or terminate the patient's responsiveness to further treatment. We have recently mapped (Dolimbek et al., 2006) the CD sera Ab-binding profile using a panel of 60, 19-residue peptides that encompassed the entire H chain sequence 449,1296 and overlapped consecutively by 5 residues. Abs in CD sera bound to one or more of the peptides N25, C10, C15, C20, and C31. This suggested the possibility that binding to these peptides could be used for assay of Abs in CD sera. Data analysis reported here found that Ab binding to these regions showed very significant deviations from the control responses. Of these four peptides, C10 showed the most significant level of separation between patient and control groups (p,=,5,×,10,7) and the theoretical resolution (i.e., ability to distinguish CD patients from control, see full definition under ,Statistical analysis' in Methods), 84%, was about 4% higher than the least resolved response, C31 (p,=,6,×,10,6, resolution 80%). Since the amounts of Abs bound to a given peptide varied with the patient and not all the patients necessarily recognized all four peptides, there was the possibility that binding to combinations of two or more peptides might give a better discriminatory capability. Using two peptides, C10 plus C31, the resolution improved to 87% (p,=,4,×,10,8). These two peptides appeared to compliment each other and negate the lower resolution of C31. Combination of three peptides gave resolutions that ranged from 85 (N25,+,C15,+,C31; p,=,2,×,10,7) to 88% (C10,+,C15,+,C31; p,=,1,×,10,8). Finally, using the data of all four peptides, N25,+,C10,+,C15,+,C31, gave a resolution of 86% (p,=,1,×,10,7). Although these levels of resolution are somewhat lower than that obtained with whole BoNT/A (resolution 97%; p,=,6,×,10,12), it may be concluded that the two-peptide combination C10,+,C31, or the three-peptide combination C10,+,C15,+,C31 (affording resolutions of 87 and 88%, respectively) provide a good diagnostic, toxin-free procedure for assay of total specific anti-toxin Abs in BoNT/A-treated CD patients. Copyright © 2006 John Wiley & Sons, Ltd. [source]